The role of Sp1 in the differential expression of transforming growth factor-β receptor type II in human breast adenocarcinoma MCF-7 cells

Yu Liu, Xiaohong Zhong, Wenhui Li, Michael G. Brattain, Sunandita S. Banerji

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Progression of MCF-7 cells from early passage (MCF-7E, <200 passage) to late passage (MCF-7L, >500 passage) correlates with a loss of sensitivity to exogenous TGFβ1. We have previously shown that loss of TGFβ sensitivity is due to decreased expression of the transforming growth factor receptor type II (TβRII) and is associated with increased tumorigenicity in nude mice. Reduced TβRII expression in MCF-7L cells is caused by decreased TβRII promoter activity in this cell line. Our previous studies using 5' deletion constructs of this promoter revealed that MCF-7L cells were unable to support transcription of the minimal promoter (-47 to +2) to the same levels as the MCF-7E cells. This region of the promoter contains an Sp1 element at position -25 from the major transcription start site. In this study, we investigated the role of Sp1 in TβRII transcription. Mutation of the Sp1 site resulted in decreased transcription of TβRII in MCF-7E and MCF-7L cells, indicating that this site played a role in transcription of this promoter. Gel shift assays using the proximal Sp1 site from the TβRII promoter showed enhanced DNA:protein complex formation with nuclear proteins isolated from MCF-7E cells compared with MCF-7L cells. Supershift analysis identified this binding activity as Sp1. Western blot analysis of Sp1 levels demonstrated that MCF-7E cells contain increased Sp1 protein compared with MCF-7L cells, paralleling the increased binding activity. Differential Sp1 activity was also demonstrated by higher levels of transcription of an Sp1-dependent insulin- like growth factor II promoter construct in MCF-7E cells compared with MCF-7L cells. Co-transfection of an Sp1 expression vector with a TβRII promoter construct in MCF-7L cells induced the expression from the promoter-CAT constructs and resulted in an increase of endogenous TβRII protein levels. These results demonstrate that the transcriptional repression of TβRII in MCF-7L cells is caused, in part, by lower Sp1 levels.

Original languageEnglish (US)
Pages (from-to)12231-12236
Number of pages6
JournalJournal of Biological Chemistry
Volume275
Issue number16
DOIs
StatePublished - Apr 21 2000

Fingerprint

Growth Factor Receptors
MCF-7 Cells
Transforming Growth Factors
Transcription
Adenocarcinoma
Breast
Proteins
Insulin-Like Growth Factor II
Transcription Initiation Site
Nuclear Proteins
Genetic Promoter Regions
Assays
Gels
Cells
DNA
Nude Mice
Transfection
Western Blotting

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

The role of Sp1 in the differential expression of transforming growth factor-β receptor type II in human breast adenocarcinoma MCF-7 cells. / Liu, Yu; Zhong, Xiaohong; Li, Wenhui; Brattain, Michael G.; Banerji, Sunandita S.

In: Journal of Biological Chemistry, Vol. 275, No. 16, 21.04.2000, p. 12231-12236.

Research output: Contribution to journalArticle

Liu, Yu ; Zhong, Xiaohong ; Li, Wenhui ; Brattain, Michael G. ; Banerji, Sunandita S. / The role of Sp1 in the differential expression of transforming growth factor-β receptor type II in human breast adenocarcinoma MCF-7 cells. In: Journal of Biological Chemistry. 2000 ; Vol. 275, No. 16. pp. 12231-12236.
@article{b3d175c472514379813f85ebabc9325b,
title = "The role of Sp1 in the differential expression of transforming growth factor-β receptor type II in human breast adenocarcinoma MCF-7 cells",
abstract = "Progression of MCF-7 cells from early passage (MCF-7E, <200 passage) to late passage (MCF-7L, >500 passage) correlates with a loss of sensitivity to exogenous TGFβ1. We have previously shown that loss of TGFβ sensitivity is due to decreased expression of the transforming growth factor receptor type II (TβRII) and is associated with increased tumorigenicity in nude mice. Reduced TβRII expression in MCF-7L cells is caused by decreased TβRII promoter activity in this cell line. Our previous studies using 5' deletion constructs of this promoter revealed that MCF-7L cells were unable to support transcription of the minimal promoter (-47 to +2) to the same levels as the MCF-7E cells. This region of the promoter contains an Sp1 element at position -25 from the major transcription start site. In this study, we investigated the role of Sp1 in TβRII transcription. Mutation of the Sp1 site resulted in decreased transcription of TβRII in MCF-7E and MCF-7L cells, indicating that this site played a role in transcription of this promoter. Gel shift assays using the proximal Sp1 site from the TβRII promoter showed enhanced DNA:protein complex formation with nuclear proteins isolated from MCF-7E cells compared with MCF-7L cells. Supershift analysis identified this binding activity as Sp1. Western blot analysis of Sp1 levels demonstrated that MCF-7E cells contain increased Sp1 protein compared with MCF-7L cells, paralleling the increased binding activity. Differential Sp1 activity was also demonstrated by higher levels of transcription of an Sp1-dependent insulin- like growth factor II promoter construct in MCF-7E cells compared with MCF-7L cells. Co-transfection of an Sp1 expression vector with a TβRII promoter construct in MCF-7L cells induced the expression from the promoter-CAT constructs and resulted in an increase of endogenous TβRII protein levels. These results demonstrate that the transcriptional repression of TβRII in MCF-7L cells is caused, in part, by lower Sp1 levels.",
author = "Yu Liu and Xiaohong Zhong and Wenhui Li and Brattain, {Michael G.} and Banerji, {Sunandita S.}",
year = "2000",
month = "4",
day = "21",
doi = "10.1074/jbc.275.16.12231",
language = "English (US)",
volume = "275",
pages = "12231--12236",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "16",

}

TY - JOUR

T1 - The role of Sp1 in the differential expression of transforming growth factor-β receptor type II in human breast adenocarcinoma MCF-7 cells

AU - Liu, Yu

AU - Zhong, Xiaohong

AU - Li, Wenhui

AU - Brattain, Michael G.

AU - Banerji, Sunandita S.

PY - 2000/4/21

Y1 - 2000/4/21

N2 - Progression of MCF-7 cells from early passage (MCF-7E, <200 passage) to late passage (MCF-7L, >500 passage) correlates with a loss of sensitivity to exogenous TGFβ1. We have previously shown that loss of TGFβ sensitivity is due to decreased expression of the transforming growth factor receptor type II (TβRII) and is associated with increased tumorigenicity in nude mice. Reduced TβRII expression in MCF-7L cells is caused by decreased TβRII promoter activity in this cell line. Our previous studies using 5' deletion constructs of this promoter revealed that MCF-7L cells were unable to support transcription of the minimal promoter (-47 to +2) to the same levels as the MCF-7E cells. This region of the promoter contains an Sp1 element at position -25 from the major transcription start site. In this study, we investigated the role of Sp1 in TβRII transcription. Mutation of the Sp1 site resulted in decreased transcription of TβRII in MCF-7E and MCF-7L cells, indicating that this site played a role in transcription of this promoter. Gel shift assays using the proximal Sp1 site from the TβRII promoter showed enhanced DNA:protein complex formation with nuclear proteins isolated from MCF-7E cells compared with MCF-7L cells. Supershift analysis identified this binding activity as Sp1. Western blot analysis of Sp1 levels demonstrated that MCF-7E cells contain increased Sp1 protein compared with MCF-7L cells, paralleling the increased binding activity. Differential Sp1 activity was also demonstrated by higher levels of transcription of an Sp1-dependent insulin- like growth factor II promoter construct in MCF-7E cells compared with MCF-7L cells. Co-transfection of an Sp1 expression vector with a TβRII promoter construct in MCF-7L cells induced the expression from the promoter-CAT constructs and resulted in an increase of endogenous TβRII protein levels. These results demonstrate that the transcriptional repression of TβRII in MCF-7L cells is caused, in part, by lower Sp1 levels.

AB - Progression of MCF-7 cells from early passage (MCF-7E, <200 passage) to late passage (MCF-7L, >500 passage) correlates with a loss of sensitivity to exogenous TGFβ1. We have previously shown that loss of TGFβ sensitivity is due to decreased expression of the transforming growth factor receptor type II (TβRII) and is associated with increased tumorigenicity in nude mice. Reduced TβRII expression in MCF-7L cells is caused by decreased TβRII promoter activity in this cell line. Our previous studies using 5' deletion constructs of this promoter revealed that MCF-7L cells were unable to support transcription of the minimal promoter (-47 to +2) to the same levels as the MCF-7E cells. This region of the promoter contains an Sp1 element at position -25 from the major transcription start site. In this study, we investigated the role of Sp1 in TβRII transcription. Mutation of the Sp1 site resulted in decreased transcription of TβRII in MCF-7E and MCF-7L cells, indicating that this site played a role in transcription of this promoter. Gel shift assays using the proximal Sp1 site from the TβRII promoter showed enhanced DNA:protein complex formation with nuclear proteins isolated from MCF-7E cells compared with MCF-7L cells. Supershift analysis identified this binding activity as Sp1. Western blot analysis of Sp1 levels demonstrated that MCF-7E cells contain increased Sp1 protein compared with MCF-7L cells, paralleling the increased binding activity. Differential Sp1 activity was also demonstrated by higher levels of transcription of an Sp1-dependent insulin- like growth factor II promoter construct in MCF-7E cells compared with MCF-7L cells. Co-transfection of an Sp1 expression vector with a TβRII promoter construct in MCF-7L cells induced the expression from the promoter-CAT constructs and resulted in an increase of endogenous TβRII protein levels. These results demonstrate that the transcriptional repression of TβRII in MCF-7L cells is caused, in part, by lower Sp1 levels.

UR - http://www.scopus.com/inward/record.url?scp=0034697288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034697288&partnerID=8YFLogxK

U2 - 10.1074/jbc.275.16.12231

DO - 10.1074/jbc.275.16.12231

M3 - Article

C2 - 10766860

AN - SCOPUS:0034697288

VL - 275

SP - 12231

EP - 12236

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 16

ER -